Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

In the July 2 release, 4DMT explained that the 25% layoffs are part of a move to “streamline operations to offset additional ...

University of Minnesota spinout Fasikl has obtained an FDA clearance for its artificial-intelligence-powered wearable for ...

Catalio Capital Management has closed its fourth venture fund with more than $400 million that will be used in part to launch ...

On Wednesday, Biokin reported (PDF) positive topline results from a phase 3 trial of the ADC. The study enrolled patients ...

AbbVie is on board with the idea. The Big Pharma will pay up to $2.1 billion in cash at closing to acquire Capstan. In return ...

AN Venture Partners has closed its first fund, a $200 million vault for biotechs worldwide, with particular emphasis on ...

Storied Japanese pharma Shionogi is upping its arsenal in the fight against antibiotic resistance. | Storied Japanese pharma ...

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...

Medtronic and Philips have re-upped their long-running partnership focused on bundling vital sign sensors together with ...

The pulsed field ablation developer Kardium has collected $250 million in funding to gear up for the commercial expansion of ...

Amgen’s investigational monoclonal antibody paired with chemotherapy significantly improved overall survival for patients in ...